Kanada - Ingliż - Health Canada

taro pharmaceuticals inc - lurasidone hydrochloride - tablet - 80mg - lurasidone hydrochloride 80mg

Kanada - Ingliż - Health Canada

taro pharmaceuticals inc - lurasidone hydrochloride - tablet - 120mg - lurasidone hydrochloride 120mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

a-s medication solutions - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - lurasidone hydrochloride tablets are indicated for: - treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see clinical studies ( 14.1)] . - monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies ( 14.2)] . - adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies ( 14.2)] . - known hypersensitivity to lurasidone hcl or any components in the formulation. angioedema has been observed with lurasidone [see adverse reactions ( 6.1)] . - strong cyp3a4 inhibitors (e.g., ketoconazol

Stati Uniti - Ingliż - NLM (National Library of Medicine)

major pharmaceuticals - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - lurasidone hydrochloride tablets are indicated for: • monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies (14.2)]. • adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies (14.2)]. • known  hypersensitivity  to  lurasidone  hcl  or  any  components  in  the  formulation. angioedema has been observed with lurasidone [see adverse reactions (6.1) ]. • strong cyp3a4 inhibitors (e.g., ketoconazole, clarithromycin, ritonavir, voriconazole, mibefradil, etc.) [see drug interactions (7.1)]. • strong cyp3a4 inducers (e.g.,  rifampin,  avasimibe,  st.  john’s wort, phenytoin, carbamazepine, etc.) [see drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lurasidone hydrochloride tabl

Stati Uniti - Ingliż - NLM (National Library of Medicine)

novadoz pharmaceuticals llc - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - lurasidone hydrochloride tablets are indicated for: • treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see clinical studies (14.1)]. • monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies (14.2)]. • adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies (14.2)]. • known hypersensitivity to lurasidone hcl or any components in the formulation.  angioedema has been observed with lurasidone [see adverse reactions (6.1)]. • strong cyp3a4 inhibitors (e.g., ketoconazole, clarithromycin, ritonavir, voriconazole, mibefradil, etc.) [see drug interactions (7.1)] . • strong cyp3a4 inducers (e.g., rifampin, avasimibe, st. john's wort, phenytoin, carbamazepine, etc.) [see drug interactions (7.1)]. pregnancy exposure registry there is

Stati Uniti - Ingliż - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - lurasidone hydrochloride is indicated for: - treatment of adult patients and adolescent patients (13 to 17 years) with schizophrenia [see clinical studies (14.1)] . - monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies (14.2)] . - adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies (14.2)] . -   known hypersensitivity to lurasidone hydrochloride or any components in the formulation.angioedema has been observed with lurasidone [see adverse reactions (6.1)] . -   strong cyp3a4 inhibitors (e.g., ketoconazole, clarithromycin, ritonavir, voriconazole, mibefradil, etc.) [see drug interactions (7.1)]. -   strong cyp3a4 inducers (e.g., rifampin, avasimibe, st. john's wort, phenytoin, carbamazepine, etc.) [see drug interactions (7.1)]. pregnancy exposure registry there

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: hypromellose; mannitol; magnesium stearate; croscarmellose sodium; titanium dioxide; iron oxide yellow; macrogol 6000; indigo carmine aluminium lake - lurasidone lapl is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; hypromellose; mannitol; titanium dioxide; macrogol 6000 - lurasidone lapl is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; mannitol; croscarmellose sodium; titanium dioxide; macrogol 6000 - lurasidone lapl is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; mannitol; pregelatinised starch; alginic acid; silicon dioxide; titanium dioxide; hypromellose; carnauba wax; macrogol 400 - lurasidone sun is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).